Scholar Rock Holding (SRRK) Prepaid Assets (2017 - 2026)
Scholar Rock Holding's (SRRK) quarterly Prepaid Assets came in at $316000.0 in Q1 2026, down 98.49% year-on-year from $20.9 million in Q1 2025, and down 78.21% quarter-over-quarter from $1.4 million in Q4 2025.
Scholar Rock Holding (SRRK) Prepaid Assets (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Prepaid Assets history runs 10 years deep, the most recent figure standing at $316000.0 for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 98.49% year-over-year to $316000.0 in Q1 2026; TTM through Mar 2026 was $316000.0, a 98.49% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 89.56% from the prior year.
- Prepaid Assets declined to $316000.0 in Q1 2026 per SRRK's latest filing, from $1.4 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $20.9 million in Q1 2025 and bottomed at $316000.0 in Q1 2026.
- The 5-year median for Prepaid Assets is $8.5 million (2024), against an average of $8.1 million.
- Across the five-year window, Prepaid Assets soared 508.81% in 2024 and tumbled 98.49% in 2026, its largest moves.
- Year by year, Prepaid Assets stood at $1.6 million in 2022, then soared by 46.97% to $2.3 million in 2023, then surged by 508.81% to $13.9 million in 2024, then sank by 89.56% to $1.4 million in 2025, then slumped by 78.21% to $316000.0 in 2026.
- Per Business Quant, the three latest SRRK Prepaid Assets figures stand at $316000.0 (Q1 2026), $1.4 million (Q4 2025), and $789000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 316,000.00 |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 789,000.00 |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 20.87 Mn |
| Dec 31, 2024 | 13.89 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 8.50 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 9.83 Mn |
| Jun 30, 2023 | 11.08 Mn |
| Mar 31, 2023 | 11.87 Mn |
| Dec 31, 2022 | 1.55 Mn |
| Sep 30, 2022 | 13.96 Mn |
| Jun 30, 2022 | 18.45 Mn |
| Mar 31, 2022 | 18.38 Mn |
| Dec 31, 2021 | 12.33 Mn |
| Sep 30, 2021 | 11.72 Mn |
| Jun 30, 2021 | 8.15 Mn |